| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964546 | Vaccine | 2014 | 6 Pages |
Abstract
Both Sabin IPV and adjuvanted Sabin IPV were well tolerated and immunogenic against all poliovirus serotypes. This result suggests that the aluminum adjuvant may allow a 50% (or higher) dose reduction.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sonia Resik, Alina Tejeda, Magilé Fonseca, Nilda Alemañi, Manuel Diaz, Yenisleidys Martinez, Gloria Garcia, Hiromasa Okayasu, Anthony Burton, Wilfried A.M. Bakker, Pauline Verdijk, Roland W. Sutter,